The Relationship of Low-Density-Lipoprotein to Lymphocyte Ratio with Chronic Obstructive Pulmonary Disease

References

• Rabe K, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940. doi:10.1016/S0140-6736(17)31222-9
   PubMed Web of Science ®Google Scholar
• Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi:10.2147/COPD.S161555
   PubMed Web of Science ®Google Scholar
• Sharafkhaneh A, Petersen N, Yu H, Dalal A, Johnson M, Hanania N. Burden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs population. Int J Chron Obstruct Pulmon Dis. 2010;5:125–132. doi:10.2147/copd.s8047
   PubMedGoogle Scholar
• McDonough J, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa1106955
   PubMed Web of Science ®Google Scholar
• Barnes P, Shapiro S, Pauwels R. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672–688. doi:10.1183/09031936.03.00040703
   PubMed Web of Science ®Google Scholar
• Güneş M, Büyükgöl H, Novel Predictive A. Marker for in-hospital mortality in acute cerebral infarction: low-density lipoprotein cholesterol to lymphocyte ratio. Cureus. 2020;12(8):e9986. doi:10.7759/cureus.9986
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy T. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365. doi:10.1056/NEJMra0800353
   PubMed Web of Science ®Google Scholar
• Shen Y, Yang T, Guo S, et al. Increased serum ox-LDL levels correlated with lung function, inflammation, and oxidative stress in COPD. Mediators Inflamm. 2013;2013:972347. doi:10.1155/2013/972347
   PubMed Web of Science ®Google Scholar
• Zafirova-Ivanovska B, Stojkovikj J, Dokikj D, et al. The level of cholesterol in COPD patients with severe and very severe stage of the disease. Open Access Maced J Med Sci. 2016;4(2):277–282. doi:10.3889/oamjms.2016.063
   PubMedGoogle Scholar
• Huang Y, Jiang B, Miao X, et al. The relationship of lymphocyte to high-density lipoprotein ratio with pulmonary function in COPD. Int J Chron Obstruct Pulmon Dis. 2020;15:3159–3169. doi:10.2147/COPD.S276372
   PubMed Web of Science ®Google Scholar
• Vogelmeier C, Criner G, Martinez F, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557–582. doi:10.1164/rccm.201701-0218PP
   PubMed Web of Science ®Google Scholar
• Chen H, Xiong C, Shao X, et al. Lymphocyte to high-density lipoprotein ratio as a new indicator of inflammation and metabolic syndrome. Diabetes Metab Syndr Obes. 2019;12:2117–2123. doi:10.2147/DMSO.S219363
   PubMed Web of Science ®Google Scholar
• Mirza S, Clay R, Koslow M, Scanlon P. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502. doi:10.1016/j.mayocp.2018.05.026
   PubMed Web of Science ®Google Scholar
• Halper-Stromberg E, Yun J, Parker M, et al. Systemic markers of adaptive and innate immunity are associated with chronic obstructive pulmonary disease severity and spirometric disease progression. Am J Respir Cell Mol Biol. 2018;58(4):500–509. doi:10.1165/rcmb.2017-0373OC
   PubMed Web of Science ®Google Scholar
• Acanfora D, Scicchitano P, Carone M, et al.; American Journal of Respiratory Cell and Molecular Biology. Relative lymphocyte count as an indicator of 3-year mortality in elderly people with severe COPD. BMC Pulm Med. 2018;18(1):116. doi:10.1186/s12890-018-0685-6
   PubMed Web of Science ®Google Scholar
• Moon S, Leem A, Kim Y, et al. Low serum lymphocyte level is associated with poor exercise capacity and quality of life in chronic obstructive pulmonary disease. Sci Rep. 2020;10(1):11700. doi:10.1038/s41598-020-68670-3
   PubMed Web of Science ®Google Scholar
• Tinè M, Bazzan E, Semenzato U, et al. Heart failure is highly prevalent and difficult to diagnose in severe exacerbations of COPD presenting to the emergency department. J Clin Med. 2020;9(8):2644. doi:10.3390/jcm9082644
   PubMed Web of Science ®Google Scholar
• Fuso L, Incalzi R, Pistelli R, et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am J Med. 1995;98(3):272–277. doi:10.1016/S0002-9343(99)80374-X
   PubMed Web of Science ®Google Scholar
• Baraldo S, Lokar Oliani K, Turato G, Zuin R, Saetta M. The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem. 2007;14(21):2250–2256. doi:10.2174/092986707781696573
   PubMed Web of Science ®Google Scholar
• Gupta S, Agrawal A, Agrawal S, Su H, Gollapudi S. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing. 2006;3:5. doi:10.1186/1742-4933-3-5
   PubMedGoogle Scholar
• Shah A, Denaxas S, Nicholas O, Hingorani A, Hemingway H. Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study. Open Heart. 2016;3(2):e000477. doi:10.1136/openhrt-2016-000477
   PubMedGoogle Scholar
• Markelić I, Hlapčić I, Rogić D, et al. Lipid profile and atherogenic indices in patients with stable chronic obstructive pulmonary disease. Nutr Metab Cardiovasc Dis. 2021;31(1):153–161. doi:10.1016/j.numecd.2020.07.039
   PubMed Web of Science ®Google Scholar
• Xuan L, Han F, Gong L, et al. Association between chronic obstructive pulmonary disease and serum lipid levels: a meta-analysis. Lipids Health Dis. 2018;17(1):263. doi:10.1186/s12944-018-0904-4
   PubMed Web of Science ®Google Scholar
• Can U, Yerlikaya F, Yosunkaya S. Role of oxidative stress and serum lipid levels in stable chronic obstructive pulmonary disease. J Chin Med Assoc. 2015;78(12):702–708. doi:10.1016/j.jcma.2015.08.004
   PubMed Web of Science ®Google Scholar
• Basili S, Ferroni P, Vieri M, et al. Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease. Atherosclerosis. 1999;147(2):249–252. doi:10.1016/S0021-9150(99)00192-6
   PubMed Web of Science ®Google Scholar
• Li C, Yan L, Song J. [COPD 患者血浆 chemerin 水平的变化及其与患者脂代谢的关系]. Zhong Nan da Xue Xue Bao Yi Xue Ban. 2016;41(7):676–683. Chinese. doi:10.11817/j.issn.1672-7347.2016.07.003
   PubMedGoogle Scholar
• Phillips C, Shivappa N, Hébert J, Perry I. Dietary inflammatory index and biomarkers of lipoprotein metabolism, inflammation and glucose homeostasis in adults. Nutrients. 2018;10(8):1033. doi:10.3390/nu10081033
   PubMed Web of Science ®Google Scholar
• Capuzzi E, Caldiroli A, Capellazzi M, et al. Exploring the role of serum lipid profile and neutrophil-to-lymphocyte ratio in violent suicide attempters: a cross sectional study. CNS Spectr. 2020;27(3):1–7.
   Web of Science ®Google Scholar
• Meng H, Matthan N, Wu D, et al. Comparison of diets enriched in stearic, oleic, and palmitic acids on inflammation, immune response, cardiometabolic risk factors, and fecal bile acid concentrations in mildly hypercholesterolemic postmenopausal women-randomized crossover trial. Am J Clin Nutr. 2019;110(2):305–315. doi:10.1093/ajcn/nqz095
   PubMed Web of Science ®Google Scholar
• Divo M, Cote C, de Torres J, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC
   PubMed Web of Science ®Google Scholar
• Hansell A, Walk J, Soriano J. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J. 2003;22(5):809–814. doi:10.1183/09031936.03.00031403
   PubMed Web of Science ®Google Scholar
• Portegies M, Lahousse L, Joos G, et al. Chronic obstructive pulmonary disease and the risk of stroke. The Rotterdam Study. Am J Respir Crit Care Med. 2016;193(3):251–258. doi:10.1164/rccm.201505-0962OC
   PubMed Web of Science ®Google Scholar
• Song Q, Chen P, Liu X. The role of cigarette smoke-induced pulmonary vascular endothelial cell apoptosis in COPD. Respir Res. 2021;22(1):39. doi:10.1186/s12931-021-01630-1
   PubMed Web of Science ®Google Scholar
• Ambrose J, Barua R. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–1737. doi:10.1016/j.jacc.2003.12.047
   PubMed Web of Science ®Google Scholar
• Chen C, Loo G. Cigarette smoke extract inhibits oxidative modification of low density lipoprotein. Atherosclerosis. 1995;112(2):177–185. doi:10.1016/0021-9150(94)05412-C
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Matsuno S, Kagota S, Haginaka J, Kunitomo M. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin. Atherosclerosis. 2004;172(2):259–265. doi:10.1016/j.atherosclerosis.2003.09.030
   PubMed Web of Science ®Google Scholar
• Schuitemaker G, Dinant G, van der Pol G, van Wersch J. Relationship between smoking habits and low-density lipoprotein-cholesterol, high-density lipoprotein-cholesterol, and triglycerides in a hypercholesterolemic adult cohort, in relation to gender and age. Clin Exp Med. 2002;2(2):83–88. doi:10.1007/s102380200011
   PubMed Web of Science ®Google Scholar
• Zhou J, Li Z, Xu X, et al. Cigarette smoke-initiated autoimmunity facilitates sensitisation to elastin-induced COPD-like pathologies in mice. Eur Respir J. 2020;56(3):2000404. doi:10.1183/13993003.00404-2020
   PubMed Web of Science ®Google Scholar